Xue Y - Search Results

1

Tailored triple plus bismuth therapy based on previous antibiotic medication history for first-line Helicobacter pylori eradication: A randomized trial.

Song Z, Suo B, Tian X, Ren X, Xue Y, Niu Z, Zhou L. Song Z, et al. Among authors: xue y. Dig Liver Dis. 2023 May;55(5):601-607. doi: 10.1016/j.dld.2022.12.019. Epub 2023 Jan 14. Dig Liver Dis. 2023. PMID: 36646526 Clinical Trial.

2

Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.

Song Z, Zhou L, Zhang J, He L, Bai P, Xue Y. Song Z, et al. Among authors: xue y. Dig Liver Dis. 2016 May;48(5):506-511. doi: 10.1016/j.dld.2016.01.002. Epub 2016 Jan 15. Dig Liver Dis. 2016. PMID: 26847964

3

Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.

Fu W, Song Z, Zhou L, Xue Y, Ding Y, Suo B, Tian X, Wang L. Fu W, et al. Among authors: xue y. Dig Dis Sci. 2017 Jun;62(6):1580-1589. doi: 10.1007/s10620-017-4564-4. Epub 2017 Apr 8. Dig Dis Sci. 2017. PMID: 28391418 Clinical Trial.

4

A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trial.

Song Z, Zhou L, Xue Y, Suo B, Tian X, Niu Z. Song Z, et al. Among authors: xue y. Helicobacter. 2020 Dec;25(6):e12762. doi: 10.1111/hel.12762. Epub 2020 Oct 11. Helicobacter. 2020. PMID: 33040439 Clinical Trial.

5

Correlation Analysis Among Genotype Resistance, Phenotype Resistance and Eradication Effect of Helicobacter pylori.

Cui R, Song Z, Suo B, Tian X, Xue Y, Meng L, Niu Z, Jin Z, Zhang H, Zhou L. Cui R, et al. Among authors: xue y. Infect Drug Resist. 2021 May 11;14:1747-1756. doi: 10.2147/IDR.S305996. eCollection 2021. Infect Drug Resist. 2021. PMID: 34012273 Free PMC article.

6

Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.

Zhou L, Zhang J, Song Z, He L, Li Y, Qian J, Bai P, Xue Y, Wang Y, Lin S. Zhou L, et al. Among authors: xue y. Helicobacter. 2016 Apr;21(2):91-9. doi: 10.1111/hel.12242. Epub 2015 Jun 23. Helicobacter. 2016. PMID: 26104022 Clinical Trial.

7

Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates.

Song Z, Zhou L, Zhang J, He L, Bai P, Xue Y. Song Z, et al. Among authors: xue y. Helicobacter. 2016 Oct;21(5):382-8. doi: 10.1111/hel.12294. Epub 2016 Jan 25. Helicobacter. 2016. PMID: 26809022

8

Recurrence of Helicobacter pylori infection: incidence and influential factors.

Xue Y, Zhou LY, Lu HP, Liu JZ. Xue Y, et al. Chin Med J (Engl). 2019 Apr 5;132(7):765-771. doi: 10.1097/CM9.0000000000000146. Chin Med J (Engl). 2019. PMID: 30897591 Free PMC article.

9

Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth.

Niu ZY, Li SZ, Shi YY, Xue Y. Niu ZY, et al. Among authors: xue y. World J Gastroenterol. 2021 Jul 7;27(25):3913-3924. doi: 10.3748/wjg.v27.i25.3913. World J Gastroenterol. 2021. PMID: 34321854 Free PMC article.

10

The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults.

Yuan Z, Xiao S, Li S, Suo B, Wang Y, Meng L, Liu Z, Yin Z, Xue Y, Zhou L. Yuan Z, et al. Among authors: xue y. Helicobacter. 2021 Dec;26(6):e12848. doi: 10.1111/hel.12848. Epub 2021 Aug 26. Helicobacter. 2021. PMID: 34448282 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,336 results

Search Page

Filters